ATAGI factsheet to GPs on AstraZeneca vaccine risks 'problematic'
The ATAGI document gives a skewed picture of risk in younger age groups, an expert says
A factsheet pitched as an aide for GPs in discussing the risks and benefits of AstraZeneca’s COVID-19 vaccine with patients under 60 is just confusing, doctors say.
Professor Robert Booy.
Last month, the Commonwealth Department of Health sent out the document detailing the risk of thrombosis with thrombocytopenia syndrome (TTS) associated with the viral-vector vaccine.
